SCHEMBL6094436

SCHEMBL6094436

Nc1cc(O)cc(C(=O)NCc2ccccc2Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
TP53 P04637 2/20 0.54
LMNA P02545 3/20 0.53
MAPT P10636 1/20 0.53
KDM4E B2RXH2 1/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 2/20 0.53
POLB P06746 1/20 0.52
LNPEP Q9UIQ6 1/20 0.52
HPGD P15428 1/20 0.51
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 2/20 0.50
SCN2A Q99250 1/20 0.50
SCN10A Q9Y5Y9 1/20 0.50
MEN1 O00255 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
GAA P10253 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6093236 0.86 SMN1; SMN2 (0.57) SMN1; SMN2TP53LMNAMAPTKDM4E
SCHEMBL6094430 0.86 SMN1; SMN2 (0.57) SMN1; SMN2TP53LMNAMAPTKDM4E
SCHEMBL23474254 0.85 KMT2A (0.60) SMN1; SMN2TP53LMNAMAPTKDM4E
SCHEMBL6093243 0.85 SMN1; SMN2 (0.56) SMN1; SMN2TP53LMNAMAPTKDM4E
SCHEMBL7592162 0.84 SMN1; SMN2 (0.57) SMN1; SMN2TP53LMNAMAPTKDM4E
SCHEMBL23511676 0.82 EPHX2 (0.61) SMN1; SMN2TP53LMNAMAPTKDM4E
SCHEMBL6093623 0.81 EPHX2 (0.57) LNPEP
SCHEMBL23511430 0.80 SMN1; SMN2 (0.50) SMN1; SMN2TP53LMNAMAPTKDM4E
SCHEMBL6094291 0.80 EGFR (0.59) SMN1; SMN2TP53LMNARAB9ALNPEP
SCHEMBL5846817 0.80 SMN1; SMN2 (0.56) SMN1; SMN2TP53LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7015223-B1 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US claimed
US-20040116430-A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-06-17 US claimed
US-6653316-B1 Coronary artery and cerebrovascular diseases PHARMACIA CORPORATION 2003-11-25 US claimed
WO-2001087851-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
WO-2001087842-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
US-7015223-B1 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US disclosed
US-6870056-B1 Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2005-03-22 US disclosed
US-20040116430-A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-06-17 US disclosed
US-6653316-B1 Coronary artery and cerebrovascular diseases PHARMACIA CORPORATION 2003-11-25 US disclosed
WO-2001087851-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed
WO-2001087842-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed